Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
37.13
-1.84 (-4.72%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Avalyn Pharma Employees
Avalyn Pharma had 55 employees as of June 30, 2026. The number of employees increased by 5 or 10.00% since the number was reported on December 31, 2025.
Employees
55
Change
5
Growth
10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,878,436
Market Cap
1.65B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 55 | 5 | 10.00% |
| Dec 31, 2025 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Ascentage Pharma Group International | 767 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Syndax Pharmaceuticals | 298 |
| Maze Therapeutics | 141 |
| Absci | 140 |
| AnaptysBio | 104 |
AVLN News
- 4 days ago - Avalyn Pharma price target raised to $57 from $53 at Morgan Stanley - TheFly
- 8 days ago - Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 8 days ago - Avalyn Pharma Quarterly report: Q2 2026 - Filings
- 8 days ago - Avalyn Pharma Earnings release: Q2 2026 - Filings
- 2 months ago - Avalyn Pharma completes target enrollment in MIST trial - TheFly
- 2 months ago - Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis - GlobeNewsWire
- 2 months ago - Avalyn Pharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire